UnknownPhase 4

Carbetocin Versus Misoprostol in High Risk Patients for Postpartum Hemorrhage After C.S.

Egypt200 participantsStarted 2014-10

Plain-language summary

We will compare between Carbitocin and Misoprostol in prevention of postpartum hemorrhage in high risk patients after C.S.

Who can participate

Age range25 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women with a singleton pregnancy undergoing cesarean section after 37 weeks of gestation. Any medical disorder with pregnancy that carries a risk factor for PPH. Exclusion Criteria: * Women undergoing cesarean section with general anesthesia will be excluded, because carbetocin is licensed for use with regional anaesthesia only. * women undergoing cesarean section at less than 37 weeks of gestation.

What they're measuring

Uterine tone and size

Timeframe: One hour after the cesarean section

Trial details

NCT IDNCT02277067

SponsorBeni-Suef University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-08

Contact for this trial

Nesreen A Shehata, MD

00201227866337 nesoomar@yahoo.com

View on ClinicalTrials.gov More Postpartum Hemorrhage trials